http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2209438-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acec9254e538f60319396ae48b8b4143 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2003-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eeb4fcb75a64a6af20223229119f47d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5d355936211c07ccc0621c25e0212ee |
publicationDate | 2003-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2209438-C1 |
titleOfInvention | Method for evaluating late gestosis severity degree |
abstract | FIELD: medicine. SUBSTANCE: method involves studying pregnant woman blood plasma treated with heparin. Leukocyte elastase activity is determined. The value being equal to 0.08-0.1 units/ml, light gestosis is considered to be the case. Leukocyte elastase activity being equal to 0.02-0.07 units/ml, moderate severity degree gestosis is considered to be the case. Leukocyte elastase activity being less than 0.02 units/ml, severe gestosis is considered to be the case. EFFECT: high accuracy and specificity of evaluation method. |
priorityDate | 2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.